Top Markets
#1 Black Phoenix Black Phoenix +354.53%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.15%
#4 Akedo Akedo +52.53%
#5 Acurast Acurast +33.26%
#6 BasedHype BasedHype +27.64%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.45%
#9 Avantis Avantis +18.91%
#10 HOME HOME +14.74%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rang in Aktien #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Aktienkurs
$0.0202
Zuletzt synchronisiert: 2024-11-19
Marktkapitalisierung
$44.67K
Veränderung (1 Tag)
-0.49%
Veränderung (1 Jahr)
0.00%
Land
IL
Handel Notable Labs, Ltd. (NTBL)

Kategorie

Healthcare
Gewinn für Notable Labs, Ltd. (NTBL)
Gewinn im Jun 2024 TTM: $-8.99M
Laut den aktuellen Finanzberichten von Notable Labs, Ltd. betragen die aktuellen Gewinne des Unternehmens $-8.99M. Im Jahr 2022 erzielte das Unternehmen einen Gewinn von $-14.41M, eine Steigerung gegenüber dem Gewinn im Jahr 2021, der $-16.05M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Notable Labs, Ltd. von 2015 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $-8.99M -20.23%
2023 $-11.26M -21.82%
2022 $-14.41M -10.25%
2021 $-16.05M -33.74%
2020 $-24.23M 24.90%
2019 $-19.40M -5.19%
2018 $-20.46M 101.80%
2017 $-10.14M -36.65%
2016 $-16.00M 7.48%
2015 $-14.89M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -58,807.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -21,810.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -33,552.61%
BE